Literature DB >> 8957461

Eosinophilia as a marker of adrenal insufficiency in the surgical intensive care unit.

M Angelis1, M Yu, D Takanishi, N W Hasaniya, M R Brown.   

Abstract

BACKGROUND: Because hemodynamic instability may have several causes in critically ill patients, adrenal insufficiency may not be readily diagnosed. Eosinophilia has been described in patients with chronic adrenal insufficiency but not in critically ill patients. The goal of this study was to determine whether eosinophilia could serve as a marker of adrenal insufficiency in critically ill patients. STUDY
DESIGN: During a 1-year period, all surgical patients admitted to the surgical intensive care unit with an eosinophil count greater than 3 percent were prospectively studied. To diagnose adrenal insufficiency, the synthetic corticotropin (cosyntropin) stimulation test was used.
RESULTS: Eosinophilia was diagnosed in 31 patients, 7 (23 percent) of whom had adrenal insufficiency. The mean time interval to diagnosis was 13.7 days (range, 4 to 39 days). In 82 percent of the patients treated with hydrocortisone, a response was evidenced within 24 hours of treatment by a decrease in the required inotropic support by more than 50 percent, an increase in the mean arterial blood pressure of more than 25 percent, or both.
CONCLUSIONS: New-onset eosinophilia may be a useful marker for adrenal insufficiency. Prompt testing and diagnosis may avoid the occurrence of a treatable, life-threatening condition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957461

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  5 in total

1.  Clinical Reasoning: An 87-year-old man with chronic obstructive pulmonary disease and acute encephalopathy.

Authors:  Kristyn Spera; Daniel Rubin; Tina Gupta; Tadeu Fantaneanu; Galen V Henderson
Journal:  Neurology       Date:  2016-09-27       Impact factor: 9.910

2.  Clinical Features and Risk Factors of Adrenal Insufficiency in Patients With Cancer Admitted to the Hospitalist-Managed Medical Unit.

Authors:  Min Kwan Kwon; Junhwan Kim; Jonghwa Ahn; Chang-Yun Woo; Hyeonjeong Kim; Hye-Seon Oh; Mingee Lee; Seungha Hwang; Keun Hoi Park; Young Hak Lee; Jakyung Yu; Sujeung Kang; Hyo-Ju Son
Journal:  J Korean Med Sci       Date:  2022-07-18       Impact factor: 5.354

Review 3.  Hypereosinophilic Syndrome.

Authors:  Casey Curtis; Princess Ogbogu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

Review 4.  Nivolumab plus ipilimumab induced endocrinopathy and acute interstitial nephritis in metastatic sarcomatoid renal-cell carcinoma: A case report and review of literature.

Authors:  Christopher Hino; Kevin Nishino; Bryan Pham; Won Jin Jeon; Michael Nguyen; Huynh Cao
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

5.  Eosinophilia in a patient with cyclical vomiting: a case report.

Authors:  Billy H Copeland; Omolola O Aramide; Salim A Wehbe; S Matthew Fitzgerald; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2004-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.